Technical Analysis for GWPH - GW Pharmaceuticals Plc

Grade Last Price % Change Price Change
grade B 137.29 2.07% 2.79
GWPH closed up 2.07 percent on Friday, January 18, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Feb 4

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical GWPH trend table...

Date Alert Name Type % Chg
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 17 180 Bullish Setup Bullish Swing Setup 2.07%
Jan 17 Pocket Pivot Bullish Swing Setup 2.07%
Jan 17 Multiple of Ten Bullish Other 2.07%
Jan 17 Wide Bands Range Expansion 2.07%
Jan 17 Overbought Stochastic Strength 2.07%

Older signals for GWPH ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GW Pharmaceuticals plc, together with its subsidiaries, engages in the research, development, and commercialization of a range of cannabinoid prescription medicines. The company primarily offers Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in treatment of cancer pain. In addition, the company has two product candidates in Phase II trials in the field of diabetes and inflammation, as well as pre-clinical research programmes evaluating the use of selected cannabinoids for the treatment of glioma, epilepsy, and psychiatric illness. It has a strategic alliance with Otsuka Pharmaceutical Co. Ltd. The company operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Salisbury, the United Kingdom.
Is GWPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 179.65
52 Week Low 90.14
Average Volume 507,155
200-Day Moving Average 138.3824
50-Day Moving Average 121.0624
20-Day Moving Average 112.4425
10-Day Moving Average 125.532
Average True Range 6.4919
ADX 26.84
+DI 32.2664
-DI 15.6391
Chandelier Exit (Long, 3 ATRs ) 117.9343
Chandelier Exit (Short, 3 ATRs ) 109.6157
Upper Bollinger Band 140.9348
Lower Bollinger Band 83.9502
Percent B (%b) 0.94
BandWidth 50.67888
MACD Line 4.2333
MACD Signal Line 0.3834
MACD Histogram 3.8499
Fundamentals Value
Market Cap 3.48 Billion
Num Shares 25.4 Million
EPS -5.64
Price-to-Earnings (P/E) Ratio -24.34
Price-to-Sales 253.36
Price-to-Book 6.23
PEG Ratio 0.33
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 142.38
Resistance 3 (R3) 141.85 139.63 141.53
Resistance 2 (R2) 139.63 138.34 139.89 141.24
Resistance 1 (R1) 138.46 137.53 139.05 138.99 140.96
Pivot Point 136.24 136.24 136.53 136.50 136.24
Support 1 (S1) 135.07 134.95 135.66 135.60 133.62
Support 2 (S2) 132.85 134.14 133.11 133.34
Support 3 (S3) 131.68 132.85 133.05
Support 4 (S4) 132.21